Did the medicine actually go in if I felt nothing?

Yes. Vitals, infusion-pump records, and CRNA observation confirm exactly what dose was delivered and over what time. Subjective experience varies enormously between patients at the same milligram-per-kilogram dose, and a quiet session does not mean the medicine was missing. Researchers measuring dissociation with the CADSS scale routinely document wide individual variability at identical doses.

Should I ask for a higher dose next time?

Sometimes a small dose adjustment makes sense, but that is a CRNA conversation, not something to self-prescribe. Marla and our medical team consider weight, vitals, anxiety levels during the first session, what you actually felt, and the goal of treatment before changing anything. A slightly slower or faster infusion rate is often tried before a dose change.

How many sessions before I know if it is working?

Most clinicians look at the response curve over four to six sessions rather than judging the protocol by session one. Our article on how many ketamine sessions are typically needed walks through the standard induction series and how we evaluate progress. Mood, sleep, energy, and pain often shift in the days between sessions rather than during the infusion itself.

Could anxiety be blocking the experience?

Yes, this is common in first sessions. Patients who arrive holding tension, watching the clock, or trying to control the experience often describe feeling almost nothing. Set, setting, breathing pace, music choice, and a brief pre-session conversation with the CRNA can change this for session two. Sometimes the body relaxes only once it knows what to expect.

What If I Feel Nothing During My Ketamine Infusion?

Q: Am I wasting a session if I feel nothing?

No. The antidepressant and pain-modulating effects of ketamine appear to depend on synaptic and glutamate-system changes that do not require an intense subjective experience. Mathew and colleagues, writing in CNS Drugs in 2012, summarized that the mechanism does not require dramatic dissociation. Many patients with quiet first sessions still report mood or pain improvement in the days that follow.

Why Patients Expect More Than They Get

Most people arrive for their first ketamine infusion with a picture in their head. That picture usually comes from secondhand sources: a podcast, a friend’s description, a Reddit thread, an article describing “ego dissolution” or vivid visual imagery. The mental rehearsal happens before the IV is even placed.

The actual experience is harder to summarize. Some patients do have the dramatic, hard-to-describe sessions they read about. Others have a session that feels closer to a slow exhale—mildly relaxed, slightly distant from anxious thoughts, possibly drowsy, and otherwise unremarkable. When the second group sits up at the end and is asked how it went, the most common phrase is some version of “I’m not sure I felt anything.”

That phrase, in our clinic, almost never means what patients fear it means. It rarely means the medicine missed. It rarely means treatment will not work. It usually means the subjective experience was quieter than expected, which is a different thing entirely. Ketamine is FDA-approved as an anesthetic; its use for depression, anxiety, PTSD, and chronic pain is off-label, and the body of clinical evidence developed over the past two decades has consistently shown that response is not the same as drama.

What “Felt Nothing” Usually Actually Means

When we sit with patients after a quiet first session and ask careful questions, the picture usually fills in. Almost no one truly feels nothing.

What patients often describe, when prompted gently, is a slight loosening of body tension, a sense that thoughts came a little slower or felt a little less sticky, a softening of the urgency around whatever brought them in, and a strong wish to simply lie still. Some report mild visual softness when they close their eyes, like a watercolor wash. Others notice that time felt longer or shorter than the clock said. None of this looks like a movie. All of it counts.

Our article on what a ketamine infusion actually feels like describes the spectrum in more detail. The point is that “nothing” is rarely the right word. “Less than I expected” is usually closer to the truth.

The Dissociation–Response Disconnect

The most useful piece of research for patients in this situation comes from the Luckenbaugh and colleagues study published in the Journal of Affective Disorders in 2014. The investigators looked at patients receiving ketamine for treatment-resistant depression and asked a direct question: does the intensity of the dissociative experience predict who gets antidepressant benefit?

The answer was complicated. In some analyses, dissociation correlated weakly with response. In others, it did not. Patients with low scores on the Clinician-Administered Dissociative States Scale—the standardized tool used to quantify dissociation—still showed antidepressant improvement. The relationship was inconsistent enough that clinicians cannot use the intensity of a session as a predictor of outcome.

Mathew and colleagues, writing in CNS Drugs in 2012, summarized why this might be. Ketamine’s antidepressant action appears to depend on downstream synaptic plasticity, BDNF release, and glutamate-system changes that begin during the infusion and continue for hours and days afterward. The dramatic subjective state is one possible side effect of NMDA blockade, but it is not the mechanism of benefit. The brain can quietly receive the relevant pharmacology without producing fireworks.

The CADSS scale itself, validated in work by Bremner and colleagues in the Journal of Traumatic Stress in 1998, was designed precisely because individual variability in dissociative response was so large. Two patients given the same milligram-per-kilogram dose can have radically different scores. That is a feature of the medicine, not evidence that one infusion was real and the other was not. Our deeper article on understanding dissociation during ketamine walks through the CADSS in more detail.

Common Reasons a First Session Feels Muted

When patients describe a quieter-than-expected first session, the cause is almost always one of a small number of factors. None are unusual. Most are addressable.

Anxiety. Patients who arrive holding tight to control—watching the clock, monitoring their own breath, mentally narrating—often clamp the experience down. The body simply does not let go on a first try. The medicine is working pharmacologically, but the experience stays bottled up.
Dose calibration. Initial sessions are dosed conservatively. We start in a range we know is safe and well tolerated, then adjust. For some patients that starting dose is enough to get clinical benefit while producing minimal subjective effect; for others, it sits below their experiential threshold.
Set and setting. Music choice, lighting, eye covering, posture, and the conversation immediately before the infusion all affect what the experience feels like. First sessions are often the most clinical-feeling because the patient does not yet know the room, the staff, or their own response.
Expectation calibration. Patients who come in expecting a vivid psychedelic experience often grade their actual session as “nothing” even when it was a meaningful pharmacological event. The mismatch between expectation and reality dominates the memory.
Caffeine, fatigue, food, and recent sleep. Physiological state on the day of the infusion shifts how the medicine lands. Our note on what to eat before and after ketamine covers the basics.

What We Adjust Before Session Two

Talking honestly with the CRNA after the session is the single most useful thing a patient can do. Specifics help us calibrate. Was there any sensation of distance from thoughts, even briefly? Any drowsiness, any softening of body tension, any change in the loudness of the inner monologue? Did anxiety dominate the early minutes? Was the music a fit?

From there, we may adjust any of several variables for session two. Dose can be raised in modest increments within evidence-based ranges. Infusion rate can be slowed or held steady longer. Music and lighting can be changed. Pre-session breathing can be coached. For patients whose first session was dominated by anxiety, our piece on managing anxiety during a ketamine session walks through the practical interventions we use. Marla Peterson, CRNA, oversees every infusion and is available throughout to make these adjustments in real time.

When to Give It More Time vs. When to Escalate

Most clinicians evaluate ketamine response over a series, not a single session. The standard induction protocol is usually four to six sessions, and our article on how many ketamine sessions are typically needed walks through the response curve in detail. Mood, sleep, energy, and pain often shift in the days between infusions rather than during them.

Trust the process for at least two to three sessions before drawing conclusions. If by session three the dose has been adjusted, the experience is still notably muted, and the days between sessions show no shifts in mood, sleep, energy, or symptoms, that is a reasonable point to revisit the plan with your CRNA. Our companion article on how to tell if ketamine is not working for you describes the markers we look at.

What Other Treatments to Consider If Ketamine Truly Isn’t Landing

For a small subset of patients, a full induction series produces neither a strong subjective experience nor meaningful clinical change. That is real, and we are honest about it. Ketamine is a powerful tool but not a universal one, and we do not promise outcomes we cannot deliver. Other evidence-based options—TMS, esketamine (Spravato), structured therapy, medication adjustments with your prescriber, and integrated approaches—all remain on the table. We never advise patients to start, stop, or change medications on their own; those conversations belong with your prescribing provider.

Cost is also a fair part of the conversation. Most insurance plans do not cover IV ketamine for off-label uses. At Music City Ketamine, sessions are $475 each. We talk about cost openly so the math is part of the decision. More on the clinical workflow and what to expect physically is in our pieces on your first ketamine infusion and how the process works overall.